COMMUNIQUÉS West-GlobeNewswire

Ascendis Pharma Initiates Global Phase 2 Trial for TransCon PTH in Adult Subjects with Hypoparathyroidism
11/02/2019
TransCon PTH is designed to provide parathyroid hormone in the physiologic range for 24 hours each day as a true replacement therapy for hypoparathyroidism COPENHAGEN, Denmark, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Ascendis [...]
Immunomedics Announces Oral Presentation at the 2019 Genitourinary Cancers Symposium
11/02/2019
MORRIS PLAINS, N.J., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
BioTelemetry, Inc. to Release Fourth Quarter 2018 Earnings Results on February 21, 2019
11/02/2019
MALVERN, Pa., Feb. 11, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2018 earnings on Thursday, February 21 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call [...]
Akorn to Report Fourth Quarter and Full Year 2018 Results
11/02/2019
LAKE FOREST, Ill., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release on Thursday, February 28, 2019 [...]
Cue Biopharma to Present Corporate Update at 2019 BIO CEO & Investor Conference
11/02/2019
CAMBRIDGE, Mass., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human [...]
Flexion Therapeutics Announces Publication of Data from Repeat Administration Trial of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) in Rheumatology and Therapy
11/02/2019
Results from Phase 3b clinical trial indicate that repeat administration of ZILRETTA for osteoarthritis (OA) knee pain was generally safe and well-tolerated X-ray data at baseline and Week 52 showed ZILRETTA had no [...]
Abeona Therapeutics Appoints João Siffert, M.D. Chief Executive Officer
11/02/2019
Former AveXis Director brings 30 years of experience to the Company NEW YORK and CLEVELAND, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company [...]
Xeris Pharmaceuticals Announces Proposed Public Offering of Shares of Common Stock
11/02/2019
CHICAGO, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable [...]
Pacific Biosciences Announces Fourth Quarter and Annual 2018 Financial Results
11/02/2019
MENLO PARK, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its fourth quarter and year ended December 31, 2018, as attached. During [...]
Poster Presented at International Stroke Conference Describing Diffusion’s On-Ambulance Phase 2 Trial with TSC for Treating Acute Stroke
11/02/2019
CHARLOTTESVILLE, Va., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) , a cutting-edge biotechnology company developing new treatments for life-threatening medical conditions by improving [...]
Veritas leads Puerto Rico partnership with approval of new Investigation License
11/02/2019
SAN JUAN, Puerto Rico, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma, Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), in partnership with [...]
Theratechnologies to Announce Financial Results for Fourth Quarter and Fiscal Year 2018
11/02/2019
MONTREAL, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) ( Theratechnologies ) announced today that it will issue its financial results for the fourth quarter and fiscal year ended November 30, 2018 [...]
Theratechnologies annoncera ses résultats du quatrième trimestre et de l’exercice financier 2018
11/02/2019
MONTRÉAL, 11 févr. 2019 (GLOBE NEWSWIRE) -- Theratechnologies inc. («Theratechnologies») (TSX : TH) a annoncé aujourd’hui qu’elle dévoilerait ses résultats financiers jeudi le 21 février 2019 pour le quatrième trimestre [...]
Kiadis Pharma to participate in a panel at Innovation for Health 2019
11/02/2019
Kiadis Pharma to participate in a panel at Innovation for Health 2019 Amsterdam, The Netherlands, February 11, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS) , a [...]
Ossur Hf : Transactions in relation to share buyback program
11/02/2019
Announcement no. 09/2019 11 February 2019 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Addus HomeCare Announces Fourth-Quarter and Year-End 2018 Earnings Release and Conference Call
11/02/2019
Frisco, Texas, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the fourth quarter and year ended December [...]
Innovation Pharmaceuticals Files Form 10-Q Quarterly Report
11/02/2019
BEVERLY, Mass., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, announces that on February 8, 2019, it filed with the U.S. Securities [...]
Biohit Oyj: Managers' Transactions
11/02/2019
BIOHIT Oyj MANAGERS’ TRANSACTIONS 11 FEBRUARY 2019 05.45 P.M. Biohit Oyj: Managers' Transactions Biohit Plc - Managers' transactions - Söderström ____________________________________________ Person subject to the [...]
Novo Nordisk A/S - Share repurchase programme
11/02/2019
Bagsværd, Denmark, 11 February 2019 - On 1 February 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Pages